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Abstract
Disruption to sleep and circadian rhythms can impact on metabolism. The study aimed to 
investigate the effect of acute sleep deprivation on plasma melatonin, cortisol and metabo-
lites, to increase understanding of the metabolic pathways involved in sleep/wake regula-
tion processes. Twelve healthy young female participants remained in controlled 
laboratory conditions for ~92 hr with respect to posture, meals and environmental light 
(18:00–23:00 hr and 07:00‐09:00 hr <8 lux; 23:00–07:00 hr 0 lux (sleep opportunity) or 
<8 lux (continuous wakefulness); 09:00–18:00 hr ~90 lux). Regular blood samples were 
collected for 70 hr for plasma melatonin and cortisol, and targeted liquid chromatogra-
phy–mass spectrometry metabolomics. Timepoints between 00:00 and 06:00 hr for day 1 
(baseline sleep), day 2 (sleep deprivation) and day 3 (recovery sleep) were analysed. 
Cosinor analysis and MetaCycle analysis were performed for detection of rhythmicity. 
Night‐time melatonin levels were significantly increased during sleep deprivation and re-
turned to baseline levels during recovery sleep. No significant differences were observed 
in cortisol levels. Of 130 plasma metabolites quantified, 41 metabolites were significantly 
altered across the study nights, with the majority decreasing during sleep deprivation, most 
notably phosphatidylcholines. In cosinor analysis, 58 metabolites maintained their rhyth-
micity across the study days, with the majority showing a phase advance during acute 
sleep deprivation. This observation differs to that previously reported for males. Our study 
is the first of metabolic profiling in females during sleep deprivation and recovery sleep, 
and offers a novel view of human sleep/wake regulation and sex differences.
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1 |  INTRODUCTION
Sleep comprises approximately one‐third of our lifetime and 
is an essential physiological function indispensable for sur-
vival. In our 24/7 lifestyle of modern society sleep duration 
has been significantly reduced and more people experience 
insufficient sleep (Deng et al., 2017). Sleep deprivation has 
been shown to impact metabolism and immune systems, 
leading to increased incidence of obesity, impaired glucose 
tolerance, metabolic syndrome and cardiovascular disease 
(Huang, Ramsey, Marcheva, & Bass, 2011; Johnston, 2014; 
Scheer, Hilton, Mantzoros, & Shea, 2009; Spiegel, Knutson, 
Leproult, Tasali, & Van Cauter, 2005).
Circadian clocks control the timing of most daily biological 
processes, behaviour and activity, including changes in metab-
olism and the sleep/wake cycle (Hastings, Reddy, & Maywood, 
2003; Mohawk, Green, & Takahashi, 2012). The master clock, 
located in the hypothalamic suprachiasmatic nuclei (SCN), 
is entrained to the external light–dark cycle by photic signals 
transmitted via the retinohypothalamic tract, and coordinates 
timing of peripheral clocks distributed throughout the body 
(Barclay et al., 2012; Reppert & Weaver, 2002). Melatonin and 
cortisol show robust circadian rhythms driven by the SCN oscil-
lator (Czeisler et al., 1999; Gunn, Middleton, Davies, Revell, & 
Skene, 2016), and melatonin is considered a reliable marker of 
the master clock (Klerman, Gershengorn, Duffy, & Kronauer, 
2002). In entrained conditions, melatonin levels rise in the eve-
ning hours, peak in the early hours of the morning and return to 
basal levels soon after waking (Arendt, 1988).
Liquid chromatography–mass spectrometry (LC/MS) 
metabolomics analysis has been employed widely to iden-
tify and quantify hundreds of metabolites in complex bi-
ological matrices such as blood, urine and saliva. Robust 
circadian rhythms in rodent (Eckel‐Mahan et al., 2012; 
Minami et al., 2009) and human metabolites have been 
identified under constant routine conditions (Dallmann, 
Viola, Tarokh, Cajochen, & Brown, 2012; Kasukawa et al., 
2012; Skene et al., 2018). Dallmann et al. (2012) reported 
that 15% of the metabolites quantified in human plasma and 
saliva showed circadian variation, particularly amino acids 
in saliva and fatty acids in plasma. Previously, we reported 
a significant time‐of‐day variation in 64% of the metab-
olites measured in healthy young men kept under a con-
trolled light/dark conditions (Davies et al., 2014). In spite 
of numerous studies on sex differences in metabolic pro-
filing (Mittelstrass et al., 2011; Rist et al., 2017; Ruoppolo 
et al., 2014), surprisingly little is known about the effect 
of sleep deprivation on metabolite profiles in females. 
As the composition of metabolites is different between 
males and females (Mittelstrass et al., 2011; Pitkanen, 
Oja, Kemppainen, Seppa, & Mero, 2003; Ruoppolo et al., 
2014), the sex‐based differences in metabolite rhythms are 
of great interest. The aim of this study was to assess the 
timing, amplitude and phase relationship of the SCN‐driven 
hormone rhythms (melatonin and cortisol) and plasma me-
tabolite rhythms with a sleep/wake cycle, during 24 hr of 
wakefulness and a recovery sleep in healthy young females. 
Assessing the effect of acute sleep deprivation on circulat-
ing metabolites and their rhythms may lead to increased 
understanding of the metabolic pathways involved in sleep/
wake regulation and development of sleep biomarkers.
2 |  MATERIALS AND METHODS
2.1 | Clinical study
Laboratory sessions were conducted at the Surrey Clinical 
Research Centre (SCRC) at the University of Surrey. Ethics 
approval for the study was given by the University of Surrey 
Ethics Committee. All participants provided written informed 
consent prior to any procedures being performed and partici-
pants were allowed to withdraw at any time. All participant in-
formation was coded and held in strictest confidence according 
to the Data Protection Act (UK, 1998). The initial screening 
phase including eligibility criteria has been reported previously 
(Ackermann et al., 2012). Briefly, study eligibility was deter-
mined by questionnaires including Pittsburgh Sleep Quality 
Index (PSQI), Epworth Sleepiness Scale (ESS), Horne‐Östberg 
(H‐O) and Beck Depression Index (BDI), medical and physi-
cal assessment, and analysis of blood and urine samples. The 
participants did not report sleep problems (PSQI score ≤5), de-
pression (BDI <10), daytime sleepiness (ESS <11) and were 
not extreme morning or evening types (30 < H‐O < 70).
Healthy females (n = 12; aged: 25 ± 4 years, mean ± SD) 
with a BMI of 24.9 ± 3.6 kg/m2 (mean ± SD) were enrolled 
into the study. All were non‐smokers and unmedicated except 
that they were taking combined oral contraceptives and were 
on the active phase during the laboratory session. None had a 
history of shift work or travel across two or more time zones 
in the preceding month. Prior to the in‐laboratory session, 
participants maintained a regular sleep/wake schedule (23:00–
07:00 hr) at home for 10 days (confirmed by wrist actigraphy 
[Actiwatch‐L, Cambridge Neurotechnology Ltd., UK] and 
sleep diaries). They were also required to have exposure to 
outdoor light each morning for at least 15 min between 07:00 
and 08:30 hr. For 72 hr before the in‐laboratory session, par-
ticipants were requested to abstain from alcohol, caffeine and 
strenuous exercise. This baseline‐at‐home period minimised 
exogenous confounding factors, stabilised circadian phase and 
ensured participants were not sleep deprived prior to the study.
2.2 | In‐laboratory session
Participants entered the laboratory at 16:00 hr on day 0 and 
remained until 12:00 hr on day 4 in a controlled environment 
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with regard to environmental light, sleep and meals, with an 
adaptation night (day 0) followed by an 8 hr sleep opportunity 
(23:00 – 07:00 hr) on day 1 (baseline sleep), total sleep depri-
vation on day 2 (sleep deprivation) and an 8 hr recovery sleep 
opportunity on day 3 (recovery sleep). Participants remained 
in <8 lux between 18:00 and 23:00 hr, and between 07:00 
and 09:00 hr each day. On days 0, 1 and 3, participants slept 
between 23:00 and 07:00 hr (0 lux), and remained awake dur-
ing this time in <8 lux on day 2. Between 09:00 and 18:00 hr 
each day, participants were free to move about in normal 
room lighting (~90 lux). The same standardised meals were 
given on each day of the study at 07:00, 13:00 and 19:00 hr 
with a snack at 22:00 hr. Blood samples were collected for 
70 hr at two hourly intervals for metabolomics analysis and 
at 1–2 hourly intervals for hormone assays (12:00 hr on day 
1–10:00 hr on day 4). Plasma fractions for metabolomics 
analysis were stored at −80°C until derivatisation; plasma 
for hormone assays were stored at −20°C until analysis. A 
detailed scheme of the study protocol is shown in Figure S1.
2.3 | Sample analysis
Plasma melatonin and cortisol concentrations were meas-
ured by radioimmunoassay (Stockgrand Ltd, University of 
Surrey) as described previously (Sletten, Revell, Middleton, 
Lederle, & Skene, 2009). Targeted LC/MS was performed 
on two‐hourly plasma samples to identify and quantify 
metabolite concentrations, using the AbsoluteIDQ p180 
targeted metabolomics kit (Biocrates Life Sciences AG, 
Innsbruck, Austria), and a Waters Xevo TQ‐S mass spec-
trometer coupled to an Acquity UPLC system (Waters 
Corporation, Milford, MA) as previously described (Davies 
et al., 2014; Isherwood, Van der Veen, Johnston, & Skene, 
2017; Skene et al., 2017). The kit provides absolute con-
centrations of 184 metabolites from six different compound 
classes (acylcarnitines, amino acids, biogenic amines, 
lysophosphatidylcholines, glycerophospholipids and sphin-
golipids). Plasma samples were prepared according to the 
manufacturer's instructions. Sample order was randomised 
and three levels of quality controls (QC) were run on each 
96‐well plate. Data were normalised between batches using 
the QC level 2 (QC2) repeats across each plate (n = 4) and 
between plates (n = 5) using Biocrates METIDQ software 
(QC2 correction). Metabolites where >25% concentrations 
were below the limit of detection (<LOD) or below lower 
limit of quantification (≪LLOQ) or above limit of quantifi-
cation (>LOQ) or blank out of range, or the QC2 coefficient 
of variance was >30%, were excluded (n = 54).
2.4 | Data analysis
Dim light melatonin onset (DLMO) for separate study days 
was calculated for each participant using the 25% threshold 
method as previously described (Sletten et al., 2009). Night‐
time melatonin levels (00:00–06:00 hr) were compared be-
tween the study nights using two‐way repeated ANOVA (R 
version 6.3.2). Significant p‐values were adjusted for mul-
tiple comparisons according to the Benjamini–Hochberg 
false discovery rate (FDR) (Benjamini & Hochberg, 1995). 
Principal component analysis (PCA) and orthogonal partial 
least squares discriminant analysis (OPLS‐DA) were per-
formed using SIMCA‐P v.13.0 software (Umetrics, Malmo, 
Sweden) to visualise the overall variation and components 
clustering between study days. To examine metabolite levels 
during the night‐time sleep periods (00:00–06:00 hr), a two‐
way repeated ANOVA was carried out (R6.3.2). To assess 24‐
hr metabolite rhythmicity, cosinor analysis was performed on 
the mean z‐score values of each study day (12:00–10:00) for 
each metabolite profile using MATLAB and Bioinformatics 
Toolbox Release 2016a (The MathWorks, Inc., Natick, 
Massachusetts, USA). Peak time (acrophase), amplitude 
and significance of a cosine fit (p < 0.05) were determined 
for each metabolite. Rhythmicity was also assessed using 
MetaCycle software (Glynn, Chen, & Mushegian, 2006; 
Hughes, Hogenesch, & Kornacker, 2010) with R6.3.2 which 
provided acrophase, amplitude and relative amplitude values 
(FDR adjusted p < 0.05). All data are shown as mean ± SEM.
3 |  RESULTS
3.1 | Hormone rhythms
Night‐time melatonin levels (00:00–06:00 hr) showed a sig-
nificant increase during sleep deprivation relative to baseline 
sleep (19% ± 7%), these levels declining back to baseline 
during recovery sleep (day 1 sleep, 84.8 ± 8.0 pg/ml; day 2 
sleep deprivation, 102.1 ± 5.6 pg/ml; day 3 recovery sleep, 
81.5 ± 4.2 pg/ml; FDR adjusted p < 0.001; Figure 1a). On 
day 1, the DLMO was 21:56 ± 0:14 hr and this did not change 
significantly between study days (day 2, 22:02 ± 0:14 hr; day 
3, 21:54 ± 0:11 hr). No significant differences were observed 
in the peak night‐time cortisol levels between the study days 
(day 1, 268 ± 62 nmol/L; day 2, 309 ± 67 nmol/L; day 3, 
287 ± 51 nmol/L; Figure 1b).
3.2 | Multivariate analysis of metabolites
A total of 130 metabolites were detected by targeted LC/MS 
metabolomics, grouped into amino acids (n = 19), acylcarni-
tines (n = 10), biogenic amines (n = 7), glycerophospholipids 
(n = 80) and sphingolipids (n = 14). Principal component anal-
ysis (PCA) of all the data showed there was clear time‐of‐day 
variation in principal component (PC)1 (amount of variance 
in the x matrix explained by PC1 (R2) = 0.367, estimate of the 
predictive ability of the model (Q2) (cumulative) = 0.358) with 
the mean score on PC1 having a significant fit to a cosine curve 
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across the study days (acrophase: 15:31, 14:04, 15:20 hr; am-
plitude: 2.14, 2.18, 1.99, day1, 2, 3, respectively) (Figure 2). 
OPLS‐DA models, validated by permutation analysis and a 
CV ANOVA p‐value of the model, showed clear separation 
between sleep (00:00–06:00 hr, day 1) and sleep deprivation 
(00:00–06:00 hr, day 2); Q2 (cumulative) = 0.641, R2X (cu-
mulative) = 0.707, R2Y (cumulative) = 0.903 (Figure 3a), 
between sleep (00:00–06:00 hr, day 1) and recovery sleep 
(00:00–06:00 hr, day 3); Q2 (cumulative) = 0.608, R2X (cu-
mulative) = 0.601, R2Y (cumulative) = 0.790 (Figure 3b), and 
between sleep deprivation (00:00–06:00 hr, day 2) and recov-
ery sleep (00:00–06:00 hr, day 3); Q2 (cumulative) = 0.439, 
R2X (cumulative) = 0.592, R2Y (cumulative) = 0.722 (Figure 
S2a). The p(corr) loading plot for the OPLS‐DA models are 
shown in Figure 3c,d and Figure S2b; metabolites with nega-
tive values decreased in sleep deprivation and metabolites with 
positive values increased in sleep deprivation. Plasma levels of 
histidine, glutamate, glutamine, lysine, carnitine, symmetric di-
methylarginine (SDMA) and six glycerophospholipids (lysoPC 
a C18:0, PC aa C36:5, PC aa C40:3, PC aa C42:2, PC ae C36:3 
and PC ae C42:2) decreased during sleep deprivation and tetra-
decenoylcarnitine, taurine, methionine levels increased during 
sleep deprivation (|p(corr)| >0.15) (Table S1).
3.3 | Univariate analysis of metabolites
Of the 130 metabolites, 41 (32%) metabolites showed 
significant differences in their night‐time concentrations 
(0:00–6:00 hr) in the study days (FDR adjusted p < 0.05); 
12 (of 19) amino acids (threonine, glycine, alanine, glu-
tamate, glutamine, histidine, lysine, asparagine, ornithine, 
methionine, arginine and proline), carnitine, two biogenic 
amines (taurine, SDMA), 25 (of 80) glycerophospholip-
ids (lysoPC a C18:0, PC aa C36:1, PC aa C36:5, PC aa 
C38:0, PC aa C38:5, PC aa C40:2, PC aa C40:3, PC aa 
C40:4, PC aa C40:5, PC aa C40:6, PC aa C42:2, PC aa 
C42:6, PC ae C34:2, PC ae C34:3, PC ae C36:0, PC ae 
C36:3, PC ae C36:4, PC ae C36:5, PC ae C38:0, PC ae 
C38:5, PC ae C38:6, PC ae C40:1, PC ae C42:1, PC ae 
C42:2 and PC ae C42:4) and 1 (of 14) sphingolipid (SM 
C20:2) (Table S2). Only 15 out of 130 metabolites (12%) 
were significantly different between the sleep and sleep 
deprivation periods, 5 amino acids (histidine, glutamate, 
threonine, lysine, citrulline), carnitine, SDMA, lysoPC a 
C18:0 and 7 phosphatidylcholines. Except threonine, all of 
these metabolites exhibited decreased levels during sleep 
deprivation compared to baseline sleep. Of these, seven 
metabolites showed a significant difference between sleep 
deprivation and recovery sleep; histidine, lysine, citrulline, 
carnitine and SDMA returned to baseline levels, two phos-
phatidylcholines (PC aa C36:5 and PC ae C42:2) showed 
a further decrease and threonine showed a further increase 
during recovery sleep (Table S3).
3.4 | Daily rhythms in metabolites
To assess rhythmic variation of the metabolites, cosinor 
analysis of the mean z‐score metabolite profiles on each 
study day was performed. Of the 130 metabolites, 33 (25%) 
metabolites showed no rhythmicity across any of the study 
days (Figure 4a). Of the 97 remaining metabolites, signifi-
cant daily rhythms were observed in 78 (60%) metabolites 
F I G U R E  1  Mean (±SEM) plasma hormone concentrations (n = 12) over the 70‐hr sampling protocol (a, melatonin; b, cortisol). The black 
bar indicates the sleep period, 0 lux, supine; grey bars, wake periods, semi‐recumbent position, <8 lux; white bars, awake and free movement, 90 
lux
F I G U R E  2  Principal component analysis of all metabolites 
data was carried out, and the significant time‐of‐day variation in mean 
score (±SEM) across all subjects on PC1 is shown. The black bar 
indicates the sleep period, 0 lux, supine; grey bars, wake periods, semi‐
recumbent position, <8 lux; white bars, awake and free movement, 90 
lux
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on day 1 (normal sleep/wake); three amino acids (asparagine, 
glutamate, glycine), valerylcarnitine, four biogenic amines 
(alpha‐Aminoadipic acid [alpha‐AAA], kynurenine, SDMA, 
trans‐4‐Hydroxyproline [t4‐OH‐Pro]), 60 glycerophospholip-
ids and 10 sphingolipids, with most metabolites (n = 63; 81%) 
peaking during the day (06:00–18:00 hr). Of these, 62 (79%) 
metabolites maintained their rhythmicity during sleep depri-
vation, with 58 (74%) maintaining their rhythmicity across all 
three study days. Metabolites (n = 58) showing daily rhythms 
across all three study days included two amino acids (aspara-
gine, glutamate), one acylcarnitine (valerylcarnitine), two bio-
genic amines (SDMA, t4‐OH‐Pro), 46 glycerophospholipids 
and seven sphingolipids (Figure 4b). Of these, the majority 
(n = 56; 97%), except valerylarnitine and SDMA, showed an 
advanced acrophase during sleep deprivation (−1.6 ± 0.1 hr), 
with the majority (n = 49; 88%) subsequently returning to base-
line timing during recovery sleep (Table S4). Metabolite data 
were also analysed with MetaCycle (JTK‐CYCLE). Using this 
analysis, significant daily rhythms were observed in only 18% 
(n = 23) of metabolites on day 1 (normal sleep/wake); namely 
two amino acids (glutamate, glycine), two biogenic amines 
(SDMA, t4‐OH‐Pro) and 19 glycerophospholipids. Of these, 12 
(52%) metabolites maintained rhythmicity on day 2 (sleep dep-
rivation) and only 8 (35%) metabolites maintained rhythmicity 
across the three study days; t4‐OH‐Pro and seven glycerophos-
pholipids (Figure S3, Table S5).
3.5 | Sex differences
In our previous study, diurnal rhythms in plasma metabolites 
in young males were also observed (Davies et al., 2014). 
Reanalysing these data using the same criteria as for the 
female data as described in the Methods above (Isherwood 
et al., 2017; Skene et al., 2017), 141 metabolites were quan-
tified. Of these, 77 (55%) exhibited a daily rhythm that 
had a significant fit to a cosine curve on day 1 (sleep) with 
most (n = 53; 69%) maintaining their 24 hr rhythmicity on 
day 2 (sleep deprivation). Of these, the majority (n = 45; 
F I G U R E  3  Orthogonal partial least squares discriminant analysis (OPLS‐DA) models of selected time points (00:00–06:00 hr) separated 
according to sleep status (a, day 1, sleep [black circle] vs. day 2, sleep deprivation [red circle]; b, day 1, sleep (black circle) vs. day 3, recovery 
sleep [blue circle]). Loading plots for the OPLS‐DA models (c, day 1, sleep vs. day 2, sleep deprivation; d, day 1, sleep vs. day 3, recovery sleep) 
coloured according to class; amino acids and biogenic amines (blue), acylcarnitines (green), glycerophospholipids (PC aa [yellow], PC ae [light 
orange], lysoPC [dark orange]) and sphingolipids (brown). Positive p (loading) values represent metabolites with higher concentrations, and 
negative p (loading) values represent metabolites with lower concentrations during sleep deprivation (c) and recovery sleep (d) compared with 
sleep. For lists of metabolites and their corresponding p (loading) values, see Table S1
6 |   HONMA et Al.
85%) showed a delay in acrophase time during sleep dep-
rivation (1.4 ± 0.2 hr) (Table S6). The mean score on PC1 
had a significant fit to a cosine curve on day 1 with an acro-
phase of 14:47 hr, but no significant fit on day 2 (15:50 hr, 
p = 0.053) (Figure S4). In a subset analysis of both sexes, 
there were 32 common metabolites that exhibited diurnal 
rhythms on day 1 and day 2. The mean acrophase time of 
these metabolites was significantly later in the female group 
on day 1 (15:48 ± 0:40 hr) compared to the male group 
(14:53 ± 0:42 hr, p < 0.001, Student's T‐test), and earlier on 
day 2 (14:29 ± 0:38 hr) compared to males (16:52 ± 0:38 hr, 
p < 0.001, Student's T‐test) (Figure 5, Table S7), although 
no significant difference in DLMO (female: 21:56 ± 0:14 hr, 
male: 21:58 ± 0:31 hr) was observed. Metabolites that were 
only rhythmic on day 1 and day 2 in females (n = 13) and 
only rhythmic in males (n = 15) are also presented in Table 
S7.
Sex differences in the metabolites affected by sleep depri-
vation were also observed (Table S8). In females, 15 (12%) 
of the 130 metabolites were significantly altered during sleep 
deprivation, all but threonine showing decreased levels. By 
contrast, in the males, 37 out of 141 metabolites (26%) exhib-
ited significant changes during sleep deprivation, all increas-
ing during sleep deprivation.
4 |  DISCUSSION
This study aimed to assess the effect of a single night of 
total sleep deprivation followed by recovery sleep under 
controlled laboratory conditions on both biomarkers of the 
central circadian pacemaker and plasma metabolic profiles 
in young females.
The pineal hormone melatonin showed significantly in-
creased plasma concentrations during sleep deprivation, 
which is in agreement with our previous study in young males 
(Ackermann et al., 2013; Davies et al., 2014), and returned to 
baseline levels during a subsequent night of recovery sleep. 
Although the mechanism underlying this increase is not 
known, we previously showed induction of a heat shock pro-
tein coding gene HSPA1B expression during sleep deprivation 
(Ackermann et al., 2012), suggesting a direct consequence 
of the oxidative stress induced by sleep loss, which may lead 
to up‐regulation of melatonin, a well‐known antioxidant 
(Carrillo‐Vico et al., 2005; Reiter, Tan, Osuna, & Gitto, 2000).
F I G U R E  4  Metabolites with a significant cosine rhythm during the three study days. (a) Venn diagram showing the number of metabolites 
exhibiting a significant fit to a cosine curve on day 1 (sleep, grey circle), day 2 (sleep deprivation, red circle), and day 3 (recovery sleep, blue 
circle). (b) Pie charts showing the proportion of metabolites from each metabolite class exhibiting a significant fit to a cosine curve on all study 
days
F I G U R E  5  Peak times (acrophase) of 31 common metabolites 
with a significant fit to a cosine curve in both males and females on 
day 1 (black circle) and day 2 (red circle). Dim light melatonin onset 
times on both days (day 1: black triangle, day 2: red triangle) are 
shown. Labelled metabolites had a difference in acrophase time of 
4 hr or more between males and females. For the details of metabolite 
acrophase times, see Table S7
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Increased melatonin levels during sleep deprivation might 
also reflect increased adrenergic stimulation (Klein & Weller, 
1973; Skene, Bojkowski, & Arendt, 1994). Sleep deprivation 
may also act directly on SCN neuronal activity reducing SCN 
output (Deboer, Detari, & Meijer, 2007) that, in turn, may 
activate melatonin synthesis via the SCN‐pineal multisyn-
aptic pathway. While we assume that the increased plasma 
levels arise from the pineal gland, there is also the possibility 
that the melatonin is derived from the gastrointestinal tract 
(GIT). The amount of melatonin in the GIT is estimated to 
be more than 400 times that of the pineal gland (Huether, 
1993). There is some evidence that food deprivation and fast-
ing increases melatonin levels in the brain and GIT of mice 
(Bubenik, Ball, & Pang, 1992) and in the serum of humans 
(Beitins et al., 1985). It can be speculated that the increased 
energy expenditure and fasting during sleep deprivation may 
induce melatonin release from the GIT into the circulation.
In our study, only 15 metabolites levels were significantly 
different between the sleep and sleep deprivation periods: 
histidine, glutamate, threonine, lysine, citrulline, carnitine, 
SDMA, lysoPC a C18:0 and seven phosphatidylcholines. 
Apart from threonine, all of these metabolites exhibited de-
creased levels during sleep deprivation. Both during the sleep 
period and during sleep deprivation, the participants were in 
a fasting state. Thus, the metabolites that changed during 
sleep deprivation were not a direct effect of fasting. However, 
the interaction of increased energy consumption during the 
sleep deprivation period and the fasting state may contribute 
to the observed metabolite differences.
l‐Histidine is an essential amino acid that is a precursor 
to histamine. Being able to cross the blood–brain barrier 
(Hargreaves & Pardridge, 1988), histidine levels in the blood 
may reflect brain histamine levels and histaminergic neuronal 
activity in the tuberomammillary nucleus, where they play 
a critical role in the maintenance of arousal (Saper, Fuller, 
Pedersen, Lu, & Scammell, 2010). The observed reduction of 
blood histidine levels during sleep deprivation may reflect its 
increased degradation into histamine as an acute response to 
sleep loss, returning to baseline levels during recovery sleep. 
Glutamate is the most abundant excitatory neurotransmitter 
in the vertebrate nervous system (Meldrum, 2000) and also 
serves as the precursor for the synthesis of the inhibitory 
gamma‐aminobutyric acid (GABA) in GABAergic neurons, 
which plays an important role in the sleep‐promoting sys-
tems in the brain (Gallopin et al., 2000; Sherin, Shiromani, 
McCarley, & Saper, 1996). Glutamine is the most abundant 
free amino acid in blood, making a large contribution to cel-
lular respiration as an energy source following glucose and 
lactate (Hui et al., 2017). Glutamate and glutamine play im-
portant roles in removing excess nitrogen, detoxifying am-
monia in the skeletal muscle, brain, kidney and liver (Adeva, 
Souto, Blanco, & Donapetry, 2012). In our study, plasma 
glutamate decreased during sleep deprivation and did not 
return to baseline levels during recovery sleep. Glutamine 
also showed a trend to decrease during sleep deprivation, 
returning to baseline levels during recovery sleep. These re-
sults can be attributed to increased energy demands and in-
creased need for removal of metabolic waste products from 
the brain during sleep deprivation (Xie et al., 2013). Diurnal 
changes in brain glutamate and glutamine levels were re-
cently observed in healthy young adults with a significant 
overnight reduction assessed by proton magnetic resonance 
spectroscopy (Volk, Jaramillo, Merki, O'Gorman Tuura, & 
Huber, 2018). In addition, a previous study reported reduced 
glutamine levels associated with lower total sleep time and 
increased wake‐time after sleep onset (Miller et al., 2017), 
supporting our hypothesis.
Carnitine plays an important role in energy production by 
conjugating fatty acids for transport into the mitochondria, by 
forming a long chain acetylcarnitine ester (Rebouche, 2004). 
Several reports have indicated a role for fatty acid β‐oxidation 
and the carnitine system in sleep/wake regulation. However, 
the role of carnitine and acylcarnitine in the brain remains un-
known. Fasting in systemic carnitine‐deficient juvenile vis-
ceral steatosis (jvs−/−) mice exhibited a higher frequency of 
fragmented wakefulness and rapid eye movement sleep, and 
reduced locomotor activity (Yoshida et al., 2006). In these 
mice, a lower percentage of c‐Fos‐positive orexin neurons, 
which regulate the sleep/wake cycle and food intake, and re-
duced orexin‐A concentration in the cerebrospinal fluid was 
observed (Yoshida et al., 2006). It has been reported that sup-
plementation of acetylcarnitine produces releasable gluta-
mate (Tanaka et al., 2003; Toth, Harsing, Sershen, Ramacci, 
& Lajtha, 1993). Orexin‐producing cells in the lateral hypo-
thalamus are mainly innervated by excitatory neurons con-
taining glutamate (Horvath & Gao, 2005; Li, Gao, Sakurai, 
& van den Pol, 2002). These findings indicate that acylcarni-
tine availability is essential for normal sleep/wake regulation 
and orexin cell functions. Thus, our results suggest increased 
acylcarnitine consumption during sleep deprivation to main-
tain wakefulness via the orexinergic arousal system.
Previous studies have indicated that cholesterol/lipid me-
tabolism is regulated by the sleep/wake cycle and that sleep 
deprivation may modify it (Jones, Pfister‐Genskow, Benca, 
& Cirelli, 2008; Moller‐Levet et al., 2013). Detailed charac-
terisation of lipid profiles, however, has remained unclear. 
In our previous study using LC/MS analysis, increases in 
blood glycerophospholipids levels were observed during the 
acute sleep deprivation period (Davies et al., 2014). Elevated 
phospholipids were also reported after sleep deprivation in 
the rat and human (Weljie et al., 2015). Another study with 
MS‐based lipidomic analysis showed increased levels of lip-
ids following sleep restriction (five nights of 4 hr/night in 
bed) compared to controls (8 hr in bed) (Aho et al., 2016). 
These authors reported that sleep loss decreased the expres-
sion of genes encoding cholesterol transporters by activating 
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inflammatory responses (Aho et al., 2016). Toll‐like recep-
tors suppress the activity of liver X receptor (LXR) regulat-
ing cholesterol metabolism (Castrillo et al., 2003; Choi et al., 
2015), which leads to decreased reverse cholesterol trans-
port and synthesis of fatty acids and triglycerides (Joseph, 
Castrillo, Laffitte, Mangelsdorf, & Tontonoz, 2003; Lee & 
Tontonoz, 2015). These findings suggest that sleep depriva-
tion/restriction modifies cholesterol pathways at the level of 
gene expression and serum lipoproteins.
Symmetric dimethylarginine is reported to be an endog-
enous marker of renal function (Kielstein, Salpeter, Bode‐
Boeger, Cooke, & Fliser, 2006) and is negatively associated 
with nitric oxide (NO) production (Bode‐Boger et al., 2006). 
As NO is reported to regulate the sleep/wake state via in-
activation of orexin neurons (Cespuglio, Amrouni, Meiller, 
Buguet, & Gautier‐Sauvigne, 2012; Yamakawa, Kurauchi, 
Hisatsune, Seki, & Katsuki, 2018), a reduction in plasma 
SDMA could be related to the disruption of sleep homeosta-
sis during the study.
Previous studies have suggested that amino acid and fatty 
acid metabolism is under circadian control (Blanco et al., 
2007; Bray & Young, 2011; Huang et al., 2011). Reverse‐erb 
alpha (REV‐ERBα), a circadian transcription gene encoding 
the nuclear orphan receptor, regulates hepatic gluconeogen-
esis, adipocyte differentiation and lipid metabolism (Duez 
& Staels, 2008). REV‐ERBα also controls oscillations in 
sterol regulatory element‐binding protein (SREBP) activity, 
through modulation of insulin‐induced gene 2, a resident 
protein of the endoplasmic reticulum, and thereby in the 
daily expression of SREBP target genes involved in choles-
terol and lipid metabolism (Le Martelot et al., 2009). These 
authors reported that alteration of oxysterol synthesis and 
LXR activity mediated the effects of REV‐ERBα on bile 
acid metabolism.
Metabolomics and lipidomics studies have analysed 
plasma samples from participants kept under constant rou-
tine laboratory conditions and found that 15% of all identi-
fied metabolites, most notably fatty acids (Dallmann et al., 
2012) and 13% of lipid metabolites (Chua et al., 2013) 
were under circadian clock control suggesting a direct ef-
fect of circadian timing on fatty acid metabolism. We our-
selves have seen 33% rhythmic glycerophospholipids under 
constant routine conditions following a simulated day shift 
(Skene et al., 2018) supporting this hypothesis. In the cur-
rent study, of the 130 metabolites identified, the largest 
group of compounds exhibiting diurnal variation across the 
three study days, was lipids (n = 46 with cosinor analysis 
and n = 7 with MetaCycle analysis), implying a robust cir-
cadian timing system underlying the daily rhythms in lipid 
metabolites. The peak phases of rhythmic phosphatidyl-
cholines and sphingolipids mostly occurred in the daytime 
(15:35 ± 0:14 hr, n = 60) which is consistent with previous 
reports (Ang et al., 2012; Dallmann et al., 2012; Davies 
et al., 2014). Interestingly, most metabolites (n = 56, 97% 
with cosinor analysis and n = 6, 75% with MetaCycle anal-
ysis) maintaining rhythmicity across the three study days 
showed a tendency to phase advance during the 24 hr of 
wakefulness, most notably the glycerophospholipids, with 
the majority returning to baseline timings during the subse-
quent recovery sleep. Besides the circadian timing system, 
the behavioural state (e.g. feeding/fasting, sleep/wakeful-
ness, postural changes) may affect the 24 hr rhythmicity of 
metabolites. Currently, we are unable to say which of these 
behaviours contribute most to the observed metabolite rhyth-
micity. Further systematic experiments are needed to accu-
rately assess the contribution of each.
Recently, sleep restriction was reported to affect cir-
cadian rhythmicity of the rodent and human transcriptome 
(Barclay et al., 2012; Moller‐Levet et al., 2013). Employing 
transcriptome analysis of human blood, Moller‐Levet et al. 
(2013) reported that the number of genes whose transcripts 
had circadian expression were reduced in sleep restriction. 
Moreover, during the sleep restriction condition, those genes 
with peak times during the biological night had later peak 
times, and genes with peak times in the biological day had 
earlier peak times. The peak phases of rhythmic metabolites 
likely relate to the physiologic pathways in which they are 
involved. For example, the fat clock promotes lipogenesis 
and adiponectin production during the wake period (Bass & 
Takahashi, 2010), which is consistent with our data of most 
phospholipids peaking during the day.
We performed two distinct analyses for assessing the daily 
rhythmicity of metabolites: cosinor analysis and MetaCycle. 
The methods showed large differences in the number of rhyth-
mic metabolites, one possible reason being that MetaCycle 
performed FDR correction of the p‐values. Thus, the data 
analysed using MetaCycle were more strictly selected, com-
prising a subset of metabolites which also showed statistical 
significance with cosinor analysis.
To our knowledge, this is the first report of metabolic pro-
filing during acute total sleep deprivation and recovery sleep 
conditions in females. Taking data from our previous study 
of healthy young males (Davies et al., 2014) and reanalysing 
with the same criteria as the current female study, 37 out of 
141 (26%) detected metabolites exhibited significant changes 
during sleep deprivation compared with during sleep, in-
cluding tryptophan, serotonin, taurine, 6 acylcarnitines, 24 
glycerophospholipids and 4 sphingolipids. All of these me-
tabolites exhibited increased levels during sleep deprivation. 
By contrast, in the current female study, only 12% (n = 15) of 
the 130 identified metabolites exhibited significant changes 
and most of these (n = 14, 93%) exhibited decreased levels 
during sleep deprivation. Although the same study protocol, 
research facilities and analytical methodology was used, the 
differences between the two studies are striking. Although 
previous studies have suggested that men and women, and 
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male and female rodents respond differently to sleep depri-
vation (Acheson, Richards, & de Wit, 2007; Baratta et al., 
2018; Ferrara et al., 2015), until now its effect on circulating 
metabolite profiles have not been investigated.
Sex differences in plasma metabolites have been reported 
with most studies showing higher levels of amino acids and 
acylcarnitine in males compared to females (Mittelstrass 
et al., 2011; Pitkanen et al., 2003; Ruoppolo et al., 2014). In 
addition, the use of oral contraceptives, as used in the current 
study, induces specific alterations in the serum metabolic sta-
tus (Ruoppolo et al., 2014). The levels of phosphatidylcholines 
and sphingolipids show a tendency to be higher in females, 
supporting an increase in lipid storage rather than metabolism 
in females (Mittelstrass et al., 2011; Rist et al., 2017).
Sleep disruption can affect peripheral clocks, where 
each tissue keeps metabolic processes in synchrony (Bass 
& Takahashi, 2010). As the utilisation of energy and met-
abolic rate are different between genders (Arciero, Goran, 
& Poehlman, 1993; Volpi, Lucidi, Bolli, Santeusanio, & De 
Feo, 1998), the timing of metabolite rhythms and their alter-
nation during sleep deprivation may vary between the sexes.
Dim light melatonin onset has been reported to be signifi-
cantly earlier in females than males (Cain et al., 2010; Mongrain, 
Lavoie, Selmaoui, Paquet, & Dumont, 2004; Van Reen et al., 
2013), but there was no difference observed in our study. Gunn 
et al. (2016) demonstrated females exhibited significantly higher 
levels of plasma melatonin and cortisol than males during a 
constant routine protocol. Our previous male study also demon-
strated increased night‐time melatonin levels during sleep depri-
vation (Davies et al., 2014), but the increase was greater in males 
than females (27 ± 5%, 19 ± 7% respectively), suggesting a sex 
difference in reaction to sleep loss/wakefulness. In addition, al-
teration in blood melatonin levels can affect metabolic profiles 
(Bass & Takahashi, 2010; Dubocovich & Markowska, 2005), 
which may relate to different trends (increase/decrease) in me-
tabolite concentrations during sleep deprivation between males 
and females. Female rodents are reported to have shorter cir-
cadian periods than males (Davis, Darrow, & Menaker, 1983; 
Schull et al., 1989), and in a human study under laboratory con-
ditions to detect intrinsic circadian period (Duffy et al., 2011), 
females indeed had a shorter  period (tau). Our data showed the 
mean acrophase of common metabolites occurred significantly 
later in females, which then advanced to earlier than that of males 
during sleep deprivation. This tendency was also  observed in the 
acrophase of the mean score on PC1 of all metabolites, with an 
advance during sleep deprivation in females but a delay in males 
(Figure 2 and Figure S4).
In the current study, the effect of the menstrual cycle was 
controlled for by only including women on hormonal contra-
ceptives. In follow‐up studies, it will be important to inves-
tigate how these metabolites vary across the menstrual cycle 
(follicular and luteal phases) and whether this is affected by 
sleep deprivation.
In conclusion, in this first report of metabolic profiling 
during sleep deprivation and recovery sleep in females, we 
have identified a panel of plasma metabolites that are sig-
nificantly altered during acute sleep deprivation and recovery 
sleep. There appears to be some differences between males 
and females in the response to sleep deprivation but, as yet, 
the underlying basis of these differences cannot be fully ex-
plained. These findings will be useful in guiding the design 
and interpretation of future metabolite‐based studies from the 
point of sex differences.
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